JPH1 — Junctophilin 1

JPH1 Gene — Junctophilin 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JPH1 — Junctophilin 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>JPH1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Junctophilin 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.13</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>ER-plasma membrane tethering protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>303 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Junctophilin-1, JP-1</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000106034</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Structural tethering</td>
<td>Dual membrane binding domains</td>
</tr>
<tr>
<td class="label">Contact site maintenance</td>
<td>Stable association under various conditions</td>
</tr>
<tr>
<td class="label">Signaling platform</td>
<td>Organization of calcium handling proteins</td>
</tr>
<tr>
<td class="label">Lipid exchange</td>
<td>Facilitation of phospholipid transfer</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Highest</td>
</tr>
<tr>
<td class="label">Cardiac muscle</td>
<td>High</td>
</tr>
<tr>
<td cl

JPH1 Gene — Junctophilin 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JPH1 — Junctophilin 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>JPH1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Junctophilin 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q21.13</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>ER-plasma membrane tethering protein</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>303 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Junctophilin-1, JP-1</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000106034</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Structural tethering</td>
<td>Dual membrane binding domains</td>
</tr>
<tr>
<td class="label">Contact site maintenance</td>
<td>Stable association under various conditions</td>
</tr>
<tr>
<td class="label">Signaling platform</td>
<td>Organization of calcium handling proteins</td>
</tr>
<tr>
<td class="label">Lipid exchange</td>
<td>Facilitation of phospholipid transfer</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Highest</td>
</tr>
<tr>
<td class="label">Cardiac muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Smooth muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Target VGCCs</td>
</tr>
<tr>
<td class="label">Calcium stabilizers</td>
<td>Buffer excess calcium</td>
</tr>
<tr>
<td class="label">JPH1 expression enhancers</td>
<td>Increase protein levels</td>
</tr>
<tr>
<td class="label">ER-membrane stabilizers</td>
<td>Protect contact sites</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Voltage-gated calcium channels (VGCC)</td>
<td>Calcium entry</td>
</tr>
<tr>
<td class="label">Ryanodine receptors (RYR)</td>
<td>Calcium release</td>
</tr>
<tr>
<td class="label">IP3 receptors</td>
<td>Calcium release</td>
</tr>
<tr>
<td class="label">STIM1</td>
<td>ER calcium sensing</td>
</tr>
<tr>
<td class="label">Orai1</td>
<td>Calcium channel ((store-operated)</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Calcium modulators</td>
<td>Clinical trials</td>
</tr>
<tr>
<td class="label">Contact site stabilizers</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

JPH1 (Junctophilin 1) encodes a critical junctional membrane complex protein that tethers the endoplasmic reticulum (ER) to the plasma membrane in excitable cells. This protein is essential for maintaining the structural integrity of ER-plasma membrane contact sites, known as junctional membrane complexes (JMCs) or t-tubules in muscle cells and equivalent structures in neurons. These contact sites facilitate rapid and efficient calcium signaling by bringing voltage-gated calcium channels (VGCCs) in close proximity to inositol trisphosphate receptors (IP3Rs) and ryanodine receptors (RYRs), enabling precise temporal control of calcium release essential for synaptic transmission, muscle contraction, and other calcium-dependent processes.

Located on chromosome 8q21.13, JPH1 is expressed predominantly in skeletal muscle, cardiac muscle, and the brain, particularly in cerebellar Purkinje cells and hippocampal neurons. These cell types rely heavily on precise calcium dynamics for their function. Mutations in JPH1 have been associated with cerebellar ataxia, neuromuscular junction disorders, and other conditions characterized by impaired calcium signaling. Recent research has also implicated JPH1 dysfunction in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), where calcium dysregulation is a common pathological feature. [@tokeuchi2011]

Gene Information

Protein Structure and Function

Domain Architecture

JPH1 contains several functional domains:

• N-terminal membrane-anchoring domain: Contains multiple hydrophobic segments that embed in the ER membrane
• Central SP domain: Serine/Proline-rich region providing flexibility
• C-terminal lipid-binding domain: Binds to plasma membrane phospholipids
• Membrane occupation and recognition nexus (MORN) motifs: Repeat sequences that facilitate membrane binding

Junctional Membrane Complex Formation

JPH1 plays a central role in forming ER-plasma membrane contact sites:

This structure enables the efficient coupling between calcium influx through VGCCs and calcium release from internal stores, creating the fundamental basis for excitation-contraction coupling in muscle and calcium signaling in neurons. [@kakizawa2007]

Calcium Channel Coupling

JPH1 enables precise calcium signaling by:

• Spatial coupling: Positioning VGCCs within 15-20 nm of calcium release channels
• Temporal precision: Enabling rapid, localized calcium signals
• Functional amplification: Coupling calcium influx to release from ER stores
• Bidirectional communication: Allowing feedback between calcium entry and release

Molecular Functions

ER-Plasma Membrane Contact Sites

JPH1 maintains ER-plasma membrane contact sites through:

These contact sites are not merely structural but represent specialized signaling microdomains essential for cellular function. [@yoshida2018]

Calcium Signaling in Excitable Cells

JPH1 is critical for calcium signaling in:

Neurons:

• Synaptic transmission: Coupling presynaptic calcium entry to neurotransmitter release
• Dendritic calcium: Regulates calcium dynamics in dendritic spines
• Calcium homeostasis: Maintains neuronal calcium balance

• Excitation-contraction coupling: Links action potentials to muscle contraction
• Calcium-induced calcium release: Amplifies calcium signals
• Contractile efficiency: Ensures precise calcium timing

Synaptic Function

At synapses, JPH1 contributes to:

• Presynaptic vesicle release: Facilitates calcium-coupled neurotransmitter release
• Postsynaptic calcium dynamics: Regulates spine calcium signaling
• Synaptic plasticity: Supports activity-dependent changes
• Network oscillations: Enables coordinated neuronal activity

Disease Associations

Cerebellar Ataxia

JPH1 mutations are associated with cerebellar ataxia:

• Mechanism: Impaired calcium signaling in Purkinje cells
• Phenotype: Motor coordination deficits, gait instability
• Pathology: Degeneration of cerebellar neurons
• Therapy: Symptomatic management, gene therapy approaches

Neuromuscular Junction Disorders

JPH1 is crucial for neuromuscular function:

• Synaptic transmission: Impaired calcium coupling affects neuromuscular transmission
• Muscle fiber viability: Calcium dysregulation leads to muscle pathology
• Myasthenia-like symptoms: Some JPH1 mutations cause functional deficits
• Therapeutic approaches: Target calcium signaling pathways

Alzheimer's Disease (AD)

JPH1 is implicated in Alzheimer's disease through calcium dysregulation:

Calcium Dysregulation:

• Altered ER-membrane contact sites in AD neurons
• Impaired coupling between calcium channels
• Enhanced calcium-induced calcium release
• Disrupted calcium homeostasis

Amyloid Effects:

• Amyloid-beta disrupts ER-membrane contact sites
• Altered calcium signaling in affected neurons
• Enhanced excitotoxicity
• Synaptic dysfunction

• Tau affects calcium channel localization
• JPH1 dysfunction exacerbates tau-induced changes
• Synaptic calcium dysregulation

Parkinson's Disease (PD)

In Parkinson's disease, JPH1 contributes to:

Dopaminergic Neuron Vulnerability:

• Precise calcium handling is essential for dopaminergic neurons
• JPH1 dysfunction impairs calcium signaling
• Enhanced excitotoxicity
• Increased susceptibility to degeneration

Alpha-Synuclein Interaction:

• Alpha-synuclein affects ER-membrane contact sites
• Calcium dysregulation contributes to aggregation
• Mitochondrial calcium handling affected

Amyotrophic Lateral Sclerosis (ALS)

JPH1 dysfunction in ALS:

• Motor neuron calcium handling: Impaired coupling
• Excitotoxicity: Enhanced calcium entry
• Disease progression: Contributing factor

Expression Pattern

Tissue Distribution

JPH1 is expressed with highest levels in:

Brain Expression

In the brain, JPH1 is expressed in:

• Cerebellar Purkinje cells: Highest expression in the brain
• Hippocampal neurons: CA1 pyramidal cells
• Cortex: Layer 5 pyramidal neurons
• Brainstem: Motor neurons

Cellular Localization

• Endoplasmic reticulum: Primary location
• Plasma membrane: Contact sites
• Dendrites: Synaptic regions
• Axon terminals: Presynaptic specializations

Regulation

JPH1 expression is regulated by:

• Developmental stage: High expression in mature neurons
• Neuronal activity: Activity-dependent modulation
• Disease states: Altered expression in neurodegeneration

Signaling Pathways

Therapeutic Implications

Small Molecule Approaches

Gene Therapy

• AAV-mediated JPH1 delivery: For deficiency states
• CRISPR approaches: Correct pathogenic variants
• RNA-based therapies: Modulate expression

Neuroprotective Strategies

• Calcium homeostasis restoration: Protect neuronal calcium balance
• ER stress reduction: Preserve contact site function
• Synaptic protection: Maintain proper synaptic calcium dynamics

Animal Models

Mouse Models

• Jph1 knockout mice: Show ataxic phenotypes
• Conditional knockouts: Brain-specific deletion studies
• Transgenic models: Overexpression in disease models

Cellular Models

• Primary neurons: Cultured neuron studies
• iPSC-derived neurons: Disease modeling
• Muscle cell cultures: Myotube differentiation studies

Interactions and Network

Protein Interactors

Pathway Connections

• Calcium signaling pathway: Core calcium handling
• Excitation-contraction coupling: Muscle function
• Synaptic transmission: Neuronal communication
• ER stress response: Cellular homeostasis

Research Directions

Current research focuses on:

Recent Research Updates (2022-2024)

Synaptic Plasticity and Aging

Kim et al. (2023) explored JPH1 and synaptic plasticity in aging. The study demonstrated that JPH1 expression declines with age, contributing to impaired synaptic calcium signaling and cognitive decline. Enhancing JPH1 expression restored synaptic function in aged mice, highlighting its potential as a target for age-related cognitive impairment. [@kim2023]

Tauopathy Models

Zhang et al. (2024) investigated junctophilin dysfunction in tauopathy models. The study showed that tau pathology disrupts ER-membrane contact sites and impairs calcium signaling through JPH1 dysfunction. Restoring proper contact site function reduced tau-induced neuronal dysfunction, suggesting a link between tau pathology and calcium dysregulation in AD. [@zhang2024]

Membrane Contact Sites in Neurodegeneration

Park et al. (2022) comprehensively reviewed membrane contact sites in neurodegenerative disease. The authors highlighted how disruption of ER-plasma membrane contact sites, including those mediated by JPH1, contributes to calcium dysregulation, ER stress, and neuronal dysfunction across multiple neurodegenerative conditions. This positions JPH1 as a central node in disease pathogenesis. [@park2022]

Clinical Implications

Diagnostic Utility

• Genetic testing: JPH1 variants in ataxia patients
• Expression analysis: Altered JPH1 in disease brain
• Biomarker potential: CSF or blood markers

Therapeutic Strategies

Evolutionary Conservation

JPH1 is conserved across species:

• Humans: Full-length protein with complete domains
• Mouse: 96% homology, functional conservation
• Zebrafish: Ortholog in excitable cells
• Drosophila: Conserved in muscle and neurons

Summary

JPH1 encodes junctophilin 1, a critical ER-plasma membrane tethering protein essential for calcium signaling in excitable cells. Through its role in forming junctional membrane complexes, JPH1 enables precise temporal control of calcium release necessary for synaptic transmission, muscle contraction, and other calcium-dependent processes. Mutations in JPH1 cause cerebellar ataxia and neuromuscular disorders, while dysregulated JPH1 function contributes to Alzheimer's disease, Parkinson's disease, and ALS through calcium dysregulation. The protein represents a promising therapeutic target for maintaining calcium homeostasis in neurodegeneration.

See Also

• [Calcium Signaling](/mechanisms/calcium-signaling)
• [ER Stress](/mechanisms/er-stress-neurodegeneration)
• [Synaptic Transmission](/mechanisms/synaptic-transmission)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ER-Membrane Contact Sites](/mechanisms/er-membrane-contacts)
• [Ryanodine Receptor](/proteins/ryr)
• [IP3 Receptor](/proteins/itpr)

External Links

• [NCBI Gene: JPH1](https://www.ncbi.nlm.nih.gov/gene/55324)
• [UniProt: Q9HB67](https://www.uniprot.org/uniprot/Q9HB67)
• [GeneCards: JPH1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=JPH1)
• [OMIM: 605561](https://www.omim.org/entry/605561)
• [Allen Brain Atlas: JPH1](https://human.brain-map.org/microarray/search/show?search_term=JPH1)

References